User Tools

Site Tools


levetiracetam

levetiracetam (Keppra)

Introduction

  • levetiracetam is a newer anticonvulsant with similar efficacy as phenytoin for status epilepticus but without the iv line incompatibility issues
  • useful for:
    • partial onset seizures (monotherapy)
    • myoclonic seizures (as add on)
    • primary generalized tonic-clonic seizures (as add on)

Use in status epilepticus

  • (off-label use)
  • iv 25mg/kg (usually 1g in adults) over 15 min
  • alternatively, some use up to 60mg/kg or 4.5g at 2 to 5 mg/kg/minute
  • although not well studied, appears to be as effective as phenytoin but without the iv line incompatibility issues but may not be as effective as sodium valproate (Epilim) as a 2nd line for status

Use in subarachnoid haemorrhage

  • (off-label use)
  • prophylaxis of seizures
  • load: iv 20mg/kg (rounded to nearest 250mg in adults) over 60 min
  • maintenance: iv 1g over 15min every 12hrs for 7 days

Adult dosing and administration

  • adjust dosing for renal impairment

iv administration

  • when switching from oral dosing to iv dosing, daily dose should be the same
  • usual initial maintenance dosing:
    • iv 500mg twice daily
    • may need to increase every 2 weeks by further 500mg/dose to max. of 1.5g bd

oral dosing

  • immediate release tablets
    • 500mg bd, may need to increase every 2 weeks by further 500mg/dose to max. of 1.5g bd
  • extended release tablets
    • initially 1g daily, increase every 2 weeks by further 1g/d as needed to max. 3g daily

Adverse effects

  • increased BP
  • behavioural issues, irritability
  • headache
  • drowsiness
  • aggressive behaviour or psychotic issues (esp. children)
  • vomiting
  • nasal congestion, nasopharyngitis?
  • eosinophilia (esp. children)
  • neutropenia or agranulocytosis
  • rarely, anaphylaxis or toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS)
  • other rare effects

C/I and warnings

  • pregnancy cat C
  • lactation
  • drug interactions
  • renal impairment increases half life

P/K

  • rapid and almost complete absorption following oral administration (100% bioavilability) with time to peak plasma concentration of around 1hr (4hrs for extended release tablets)
  • Vd similar to water (0.5-0.7L/kg)
  • less than 25% metabolised, mainly renal excretion with half life of 6-8hrs for adults and 4-7hrs for children
levetiracetam.txt · Last modified: 2018/12/21 02:27 by 127.0.0.1

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki